| scholarly article | Q13442814 |
| P2093 | author name string | Hidetaka Yamamoto | |
| Yoshinao Oda | |||
| Masazumi Tsuneyoshi | |||
| Sachiyo Suita | |||
| Yukiko Takahashi | |||
| Sadafumi Tamiya | |||
| Ken-Ichi Kawaguchi | |||
| P2860 | cites work | The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 |
| Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 | Q29615851 | ||
| Mechanisms of p53 loss in human sarcomas | Q33722859 | ||
| Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma | Q34207682 | ||
| Molecular pathogenesis of rhabdomyosarcoma | Q34779149 | ||
| P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines | Q40864851 | ||
| Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma | Q43623316 | ||
| Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children. | Q44925915 | ||
| MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma | Q44984040 | ||
| Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease. | Q45947856 | ||
| Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma | Q48657987 | ||
| Immunohistochemical detection of p53 protein in rhabdomyosarcoma: association with clinicopathological features and outcome. | Q50968542 | ||
| High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities | Q56566036 | ||
| Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas | Q68184562 | ||
| Altered expression of the retinoblastoma gene product in human sarcomas | Q68593145 | ||
| Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas | Q70525044 | ||
| Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors | Q71513567 | ||
| Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma | Q73009035 | ||
| Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas | Q73622335 | ||
| Mutation analysis of p53 gene in childhood malignant solid tumors | Q73622699 | ||
| Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years | Q74615780 | ||
| H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients | Q77953988 | ||
| p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study | Q78947823 | ||
| P433 | issue | 6 | |
| P921 | main subject | rhabdomyosarcoma | Q1898141 |
| P304 | page(s) | 660-669 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma | |
| P478 | volume | 17 |
| Q56997205 | A magnetic electrochemical immunosensor for the detection of phosphorylated p53 based on enzyme functionalized carbon nanospheres with signal amplification |
| Q55265062 | A review of soft-tissue sarcomas: translation of biological advances into treatment measures. |
| Q37580831 | Advances in pediatric rhabdomyosarcoma characterization and disease model development |
| Q36588372 | Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis |
| Q37598848 | Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. |
| Q34235576 | Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers |
| Q36093810 | CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma |
| Q36240990 | Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement |
| Q37881290 | Developmental origins of fusion-negative rhabdomyosarcomas. |
| Q34580128 | Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma |
| Q33819295 | Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH |
| Q24319144 | IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS) |
| Q83051301 | Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades |
| Q45947620 | Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas. |
| Q34162514 | Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice |
| Q30411722 | Lineage of origin in rhabdomyosarcoma informs pharmacological response |
| Q35897781 | Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma |
| Q34999483 | MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. |
| Q54239289 | MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts. |
| Q26852728 | Mechanisms of impaired differentiation in rhabdomyosarcoma |
| Q42947899 | Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts |
| Q37630588 | Molecular and cellular biology of rhabdomyosarcoma. |
| Q37343475 | Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway |
| Q30437251 | PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma |
| Q38105879 | Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. |
| Q34255856 | Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma |
| Q33800135 | Rhabdomyosarcoma in adolescent and young adult patients: current perspectives |
| Q34121419 | Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy. |
| Q90733025 | Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers |
| Q41303735 | Targeting the p53 Pathway in Ewing Sarcoma. |
| Q48104644 | Ultraviolet A eye irradiation ameliorates colon carcinoma induced by azoxymethane and dextran sodium sulfate through β-endorphin and methionine-enkephalin. |
Search more.